Ponezumab Explained

Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease.[1] [2]

Ponezumab was developed by Pfizer Inc.In November 2011 Pfizer halted the development of ponezumab after finishing a phase 2 trial.[3]

Notes and References

  1. Web site: Statement On A Nonproprietary Name Adopted By The USAN Council: Ponezumab. American Medical Association.
  2. Book: Popescu CD, Trofin D, Ignat B, Matei D . New Aspects of Therapeutic Management in Alzheimer`s Disease . Atta-ur-Rahman . Frontiers in Clinical Drug Research: Alzheimer Disorders . 3 . 2014 . Bentham Science Publishers . Sharjah . 978-1-68108-068-0 . 10.2174/9781681080680115030004 . 55 .
  3. Web site: Alzforum.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Ponezumab".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.